Guidance for industry, FDA staff, and FDA-accredited third parties
Subtitle: Manufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)
Contributors: Center for Biologics Evaluation and Research (U.S.)
Publisher: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health; Center for Biologics Evaluation and Research
Published: 2009
Place of publication: Rockville, Md.]; [Bethesda, Md.]
Language: eng
Format: [electronic resource]
Number of pages: 10
Subjects: Medical instruments and apparatus; Government policy; United States. Food and Drug Administration; United States
Other titles: Guidance for industry, Food and Drug Administration staff, and Food and Drug Administration accredited third parties.; Manufacturer's notification of the intent to use accredited person under the accredited person inspection program authorized by Section 228 of the Food and Drug Administration Amendments Act of 2007 (FDAAA)
Notes: Title from PDF title screen (viewed May 24, 2012).

"Document issued on March 2, 2009."

"This document supercedes the document which was issued on September 15, 2005."